Company Summary - Ransom (William) & Son PLC (LSE:RNSM)
6.25p
0.50p
(8.70%)
FTSE AIM All Share Pharmaceuticals & BiotechnologyMarket cap: £5.277m
Review a company's summary page in more detail and see the key fundamentals at a glance. Sign-up to Premium now to make your investment decisions.
Sign-up to Premium's Free 7 Day trial See an improved company summary
Summary
Supply natural health products & a pharmaceutical company
| Financials - Interim (24/12/2009) | ||
|---|---|---|
| Turnover | £m | 16.74 |
| Pre-tax Profit | £m | -2.81 |
| EPS | p | -0.05 |
| DPS | p | 0.00 |
| Director | Board Role |
|---|---|
| David Suddens | Chairman |
| Ivor Harrison | Chief Executive |
| Ran Oren | Finance Director |
Products Brands & Subsidiaries
Products & Brands
There are no products for this company.
Subsidiaries
Optima Italia srl
Broker Sentiment (1 brokers)
Strong SellStrong Buy
| Heading | Date |
|---|---|
| Notification of Major Interests In S... | 23/02/2010 |
| Medibee and Debt Restructure | 16/02/2010 |
| Notification of Major Interests In S... | 09/02/2010 |
For more information
and investor relations, visit the
Ransom (William) & Son PLC company website: